These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34694988)

  • 1. The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences.
    Yousef M; Silva D; Bou Chacra N; Davies N; Löbenberg R
    J Pharm Pharm Sci; 2021; 24():533-547. PubMed ID: 34694988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic Drug Transport and Associated Drug Delivery Technologies: A Comprehensive Review.
    Punjabi MS; Naha A; Shetty D; Nayak UY
    Curr Pharm Des; 2021; 27(17):1992-1998. PubMed ID: 33272166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
    Managuli RS; Raut SY; Reddy MS; Mutalik S
    Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Participation of the lymphatic system in the metastasis of malignant tumors].
    Kraev AV; Levin IuM; Nikitina RG
    Vopr Onkol; 1977; 23(7):74-83. PubMed ID: 906400
    [No Abstract]   [Full Text] [Related]  

  • 5. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate.
    Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS
    Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic Transport of Drugs after Intestinal Absorption: Impact of Drug Formulation and Physicochemical Properties.
    Ryšánek P; Grus T; Šíma M; Slanař O
    Pharm Res; 2020 Aug; 37(9):166. PubMed ID: 32770268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
    Franco V; Gershkovich P; Perucca E; Bialer M
    Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
    Ali Khan A; Mudassir J; Mohtar N; Darwis Y
    Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic Drug Absorption via the Enterocytes: Pharmacokinetic Simulation, Modeling, and Considerations for Optimal Drug Development.
    Brocks DR; Davies NM
    J Pharm Pharm Sci; 2018; 21(1s):254s-270s. PubMed ID: 30348249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic Delivery of Anti-HIV Drug Nanoparticles.
    Nayak Y; Avadhani K; Mutalik S; Nayak UY
    Recent Pat Nanotechnol; 2016; 10(2):116-27. PubMed ID: 27502389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid lipid nanoparticle-based dissolving microneedles: A promising intradermal lymph targeting drug delivery system with potential for enhanced treatment of lymphatic filariasis.
    Permana AD; Tekko IA; McCrudden MTC; Anjani QK; Ramadon D; McCarthy HO; Donnelly RF
    J Control Release; 2019 Dec; 316():34-52. PubMed ID: 31655132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipidic prodrug approach for improved oral drug delivery and therapy.
    Markovic M; Ben-Shabat S; Keinan S; Aponick A; Zimmermann EM; Dahan A
    Med Res Rev; 2019 Mar; 39(2):579-607. PubMed ID: 30320896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved lymphatic targeting: effect and mechanism of synthetic borneol on lymph node uptake of 7-ethyl-10-hydroxycamptothecin nanoliposomes following subcutaneous administration.
    Ye T; Wu Y; Shang L; Deng X; Wang S
    Drug Deliv; 2018 Nov; 25(1):1461-1471. PubMed ID: 29902927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.
    Chaudhary S; Garg T; Murthy RS; Rath G; Goyal AK
    J Drug Target; 2014 Dec; 22(10):871-82. PubMed ID: 25148607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin.
    Ryan GM; Kaminskas LM; Bulitta JB; McIntosh MP; Owen DJ; Porter CJH
    J Control Release; 2013 Nov; 172(1):128-136. PubMed ID: 23954628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy.
    Abellan-Pose R; Csaba N; Alonso MJ
    Curr Pharm Des; 2016; 22(9):1194-209. PubMed ID: 26675222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
    Trevaskis NL; Kaminskas LM; Porter CJ
    Nat Rev Drug Discov; 2015 Nov; 14(11):781-803. PubMed ID: 26471369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic lymphatic targeting drug delivery system using carbon nanotubes.
    Yang F; Fu de L; Long J; Ni QX
    Med Hypotheses; 2008; 70(4):765-7. PubMed ID: 17910909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.